Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1992 1
1993 1
1995 1
1996 1
1997 1
1998 1
1999 1
2000 3
2001 5
2002 4
2003 3
2004 2
2005 6
2006 11
2007 7
2008 11
2009 7
2010 11
2011 9
2012 8
2013 8
2014 11
2015 12
2016 10
2017 11
2018 6
2019 11
2020 19
2021 14
2022 12
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for progress choong
Your search for Progress Choongo retrieved no results
Key Echocardiographic Considerations for Tricuspid Valve Transcatheter Edge-to-Edge Repair.
Hungerford SL, Rye EE, Hansen PS, Bhindi R, Choong C. Hungerford SL, et al. J Am Soc Echocardiogr. 2023 Apr;36(4):366-380.e1. doi: 10.1016/j.echo.2023.01.013. Epub 2023 Feb 6. J Am Soc Echocardiogr. 2023. PMID: 36754098 Review.
Chronic tricuspid regurgitation (TR) results in progressive right ventricular (RV) volume overload, followed by right-sided chamber dilatation, RV systolic dysfunction, and eventual low-output cardiac failure. Severe TR is associated with considerable morbidity and mortali …
Chronic tricuspid regurgitation (TR) results in progressive right ventricular (RV) volume overload, followed by right-sided chamber d …
Early mobilization in the critical care unit: A review of adult and pediatric literature.
Cameron S, Ball I, Cepinskas G, Choong K, Doherty TJ, Ellis CG, Martin CM, Mele TS, Sharpe M, Shoemaker JK, Fraser DD. Cameron S, et al. J Crit Care. 2015 Aug;30(4):664-72. doi: 10.1016/j.jcrc.2015.03.032. Epub 2015 Apr 8. J Crit Care. 2015. PMID: 25987293 Review.
Early mobilization of critically ill patients is beneficial, suggesting that it should be incorporated into daily clinical practice. Early passive, active, and combined progressive mobilizations can be safely initiated in intensive care units (ICUs). ...
Early mobilization of critically ill patients is beneficial, suggesting that it should be incorporated into daily clinical practice. Early p …
Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.
Larkin J, Ascierto PA, Dréno B, Atkinson V, Liszkay G, Maio M, Mandalà M, Demidov L, Stroyakovskiy D, Thomas L, de la Cruz-Merino L, Dutriaux C, Garbe C, Sovak MA, Chang I, Choong N, Hack SP, McArthur GA, Ribas A. Larkin J, et al. N Engl J Med. 2014 Nov 13;371(20):1867-76. doi: 10.1056/NEJMoa1408868. Epub 2014 Sep 29. N Engl J Med. 2014. PMID: 25265494 Free article. Clinical Trial.
METHODS: We randomly assigned 495 patients with previously untreated unresectable locally advanced or metastatic BRAF V600 mutation-positive melanoma to receive vemurafenib and cobimetinib (combination group) or vemurafenib and placebo (control group). The primary end point was i …
METHODS: We randomly assigned 495 patients with previously untreated unresectable locally advanced or metastatic BRAF V600 mutation-positive …
Neuropathology of alpha-synuclein in Parkinson's disease.
Choong CJ, Mochizuki H. Choong CJ, et al. Neuropathology. 2022 Apr;42(2):93-103. doi: 10.1111/neup.12812. Epub 2022 Mar 31. Neuropathology. 2022. PMID: 35362115 Review.
Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive movement disability accompanied by non-motor symptoms. The neuropathology hallmark of PD is the loss of dopaminergic neurons predominantly in the substantia nigra pars compacta and …
Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive movement disability accompanied by non-m …
Reprogramming cancer cells: overview & current progress.
Lim KL, Teoh HK, Choong PF, Teh HX, Cheong SK, Kamarul T. Lim KL, et al. Expert Opin Biol Ther. 2016 Jul;16(7):941-51. doi: 10.1517/14712598.2016.1174211. Epub 2016 Apr 21. Expert Opin Biol Ther. 2016. PMID: 27070264 Review.
INTRODUCTION: Cancer is a disease with genetic and epigenetic origins, and the possible effects of reprogramming cancer cells using the defined sets of transcription factors remain largely uninvestigated. ...In this review we will provide an overview on i) methods to repro …
INTRODUCTION: Cancer is a disease with genetic and epigenetic origins, and the possible effects of reprogramming cancer cells using t …
Progress in ion torrent semiconductor chip based sequencing.
Merriman B; Ion Torrent R&D Team; Rothberg JM. Merriman B, et al. Electrophoresis. 2012 Dec;33(23):3397-417. doi: 10.1002/elps.201200424. Electrophoresis. 2012. PMID: 23208921 Review.
Here we provide an overview of this semiconductor chip based sequencing technology, and summarize the progress made since its commercial introduction. We described in detail the progress in chip scaling, sequencing throughput, read length, and accuracy. ...
Here we provide an overview of this semiconductor chip based sequencing technology, and summarize the progress made since its commerc …
36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N, Rajas O, Briones M, Rodríguez de Castro F, Rodríguez Gallego C, Esen F, Orhun G, Ergin Ozcan P, Senturk E, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Kucukerden M, Giris M, Akcan U, Bilgic Gazioglu S, Tuzun E, Riff R, Naamani O, Douvdevani A, Takegawa R, Yoshida H, Hirose T, Yamamoto N, Hagiya H, Ojima M, Akeda Y, Tasaki O, Tomono K, Shimazu T, Ono S, Kubo T, Suda S, Ueno T, Ikeda T, Hirose T, Ogura H, Takahashi H, Ojima M, Kang J, Nakamura Y, Kojima T, Shimazu T, Ikeda T, Suda S, Izutani Y, Ueno T, Ono S, Taniguchi T, O M, Dinter C, Lotz J, Eilers B, Wissmann C, Lott R, Meili MM, Schuetz PS, Hawa H, Sharshir M, Aburageila M, Salahuddin N, Chantziara V, Georgiou S, Tsimogianni A, Alexandropoulos P, Vassi A, Lagiou F, Valta M, Micha G, Chinou E, Michaloudis G, Kodaira A, Ikeda T, Ono S, Ueno T, Suda S, Izutani Y, Imaizumi H, De la Torre-Prados MV, Garcia-De la Torre A, Enguix-Armada A, Puerto-Morlan A, Perez-Valero V, Garcia-Alcantara A, Bolton N, Dudziak J, Bonney S, Tridente A, Nee P, Nicolaes G, Wiewel M, Schultz M, Wildhag… See abstract for full author list ➔ Bateman RM, et al. Crit Care. 2016 Apr 20;20(Suppl 2):94. doi: 10.1186/s13054-016-1208-6. Crit Care. 2016. PMID: 27885969 Free PMC article.
Resche-Rigon, E. Vicaut, A. Vieillard-Baron, A. Mebazaa P020 - Impact of disease severity assessment on performance of heparin-binding protein for the prediction of septic shock R. ...Simants, I. Patanwala, I. Welters P277 - Risk of coronary artery disease in patien …
Resche-Rigon, E. Vicaut, A. Vieillard-Baron, A. Mebazaa P020 - Impact of disease severity assessment on performance of heparin-bindin …
[Evolution and miniaturization of percutaneous nephrolithotomy].
Schoofs F, Celentano G, Abboudi H, Choong S, Iselin C, Wirth G. Schoofs F, et al. Rev Med Suisse. 2019 Nov 27;15(673):2198-2201. Rev Med Suisse. 2019. PMID: 31778049 Review. French.
Percutaneous nephrolithotomy (PCNL) was at first indicated for larger renal stones. Technological progress allowed a significant improvement of the available equipment, mostly to miniaturize the devices. ...
Percutaneous nephrolithotomy (PCNL) was at first indicated for larger renal stones. Technological progress allowed a significant impr …
Lysophagy protects against propagation of α-synuclein aggregation through ruptured lysosomal vesicles.
Kakuda K, Ikenaka K, Kuma A, Doi J, Aguirre C, Wang N, Ajiki T, Choong CJ, Kimura Y, Badawy SMM, Shima T, Nakamura S, Baba K, Nagano S, Nagai Y, Yoshimori T, Mochizuki H. Kakuda K, et al. Proc Natl Acad Sci U S A. 2024 Jan 2;121(1):e2312306120. doi: 10.1073/pnas.2312306120. Epub 2023 Dec 26. Proc Natl Acad Sci U S A. 2024. PMID: 38147546 Free PMC article.
These results indicate that lysophagy prevents exogenous alphaSyn aggregates from escaping the endosomal-lysosomal system and transmitting aggregation to endogenous cytosolic alphaSyn via ruptured lysosomal vesicles. Our findings suggest that the progression and severity o …
These results indicate that lysophagy prevents exogenous alphaSyn aggregates from escaping the endosomal-lysosomal system and transmitting a …
Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions.
Gavor E, Choong YK, Er SY, Sivaraman H, Sivaraman J. Gavor E, et al. Trends Immunol. 2020 Nov;41(11):1006-1022. doi: 10.1016/j.it.2020.09.004. Epub 2020 Sep 17. Trends Immunol. 2020. PMID: 33041212 Free PMC article. Review.
We focus here on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV, and discuss current progress in antibody research against rampant SARS-CoV-2 infections. ...We also propose ways of adopting antibody-based strategies - such as cocktail antibody th …
We focus here on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV, and discuss current progress in antibody …
190 results